| scholarly article | Q13442814 |
| P2093 | author name string | Heidi M Schaefer | |
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Report of the expert committee on the diagnosis and classification of diabetes mellitus | Q34167177 | ||
| Malignancy in renal transplantation | Q35778329 | ||
| Prevention of infection in adult travelers after solid organ transplantation | Q36001738 | ||
| Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials | Q36087152 | ||
| Guidelines for the treatment and management of new-onset diabetes after transplantation | Q36118632 | ||
| Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation | Q36155827 | ||
| Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials | Q36155850 | ||
| Anemia, renal transplantation, and the anemia paradox | Q36584143 | ||
| Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence | Q36653136 | ||
| Infection in solid-organ transplant recipients | Q37038203 | ||
| Evaluation and management of bone disease and fractures post transplant | Q37218101 | ||
| Hyperlipidemia in solid organ transplantation. | Q41353423 | ||
| The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients | Q43114684 | ||
| Angiotensin converting enzyme inhibition in chronic allograft nephropathy | Q43926383 | ||
| Trends in organ donation and transplantation in the United States, 1999-2008. | Q44125408 | ||
| Diabetes mellitus after kidney transplantation in the United States | Q44326129 | ||
| Rapid loss of vertebral mineral density after renal transplantation | Q44431557 | ||
| Prevalence and management of anemia in renal transplant recipients: a European survey. | Q44482856 | ||
| Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate | Q44599938 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| The burden of chronic kidney disease in renal transplant recipients | Q44770925 | ||
| Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative | Q44803518 | ||
| fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study | Q44899028 | ||
| Hypertension after kidney transplantation | Q44914562 | ||
| Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies | Q44963400 | ||
| Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. | Q45091871 | ||
| Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population | Q46452967 | ||
| Excess risk of renal allograft loss associated with cigarette smoking | Q49250324 | ||
| Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. | Q50654391 | ||
| Cardiovascular complications after renal transplantation and their prevention. | Q50788889 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 205-211 | |
| P577 | publication date | 2012-01-20 | |
| P1433 | published in | Blood Purification | Q15759923 |
| P1476 | title | Long-term management of the kidney transplant recipient | |
| P478 | volume | 33 |
| Q57789525 | Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose? |
| Q33571836 | Clinical and economic outcomes associated with medication errors in kidney transplantation |
| Q44355210 | Kidney transplant recipients with functioning grafts for more than 15 years. |
Search more.